Feasibility and Potential Impact of an Individualized Exercise Program Via a Telerehabilitation Device in Chronic Patients: A Pilot Study
Launched by LIMOGES UNIVERSITY · Aug 14, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of a special device called ADEPINA to help patients with chronic diseases improve their physical fitness through a personalized exercise program delivered remotely. The study aims to see if this approach can lead to better walking ability, strength, balance, and overall quality of life after 12 weeks of exercise sessions. Participants will be asked to use the device 2 to 3 times a week, and researchers will monitor how well they stick to the program and their progress.
To be eligible for the trial, participants must be at least 18 years old, able to walk (even with assistance), and registered with the French health system. They should also be under the care of a qualified exercise rehabilitation professional. Patients who have difficulty using digital tools or have certain health conditions that prevent them from exercising safely will not be included. This pilot study hopes to find effective ways to support patients in their rehabilitation and gather important information on how individualized telerehabilitation can work.
Gender
ALL
Eligibility criteria
- Inclusion Criteria for professionals of exercise rehabilitation (ER):
- • Be a physiotherapist or kinesiologist working in the public sector, private sector, or in a mixed capacity,
- • Have been graduated for at least one year,
- • Conduct ER program with chronic patients and provide written consent.
- Inclusion Criteria for chronic patients :
- • Be 18 years of age or older,
- • Be able to walk with or without assistives devices
- • Be capable of giving informed consent,
- • Be registered with the French health social security system,
- • Be under the care of a rehabilitation exercise professional.
- Non-inclusion criteria for patients :
- • Have an intolerance or inability to use digital tools,
- • Have a cognitive impairment,
- • Have contraindications to physical activity (unstable diabetes, unstable hypertension, unstable angina, intracardiac thrombus).
About Limoges University
Limoges University, a leading academic institution in France, is dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts a wide range of clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, Limoges University is committed to fostering advancements in medical science through rigorous study designs and ethical standards, ultimately contributing to the global body of knowledge in the field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported